This measure would state the intent of the Legislature to take the opportunity preceding the 4th of July holiday to recognize and celebrate July 4, 2018, and the 242nd anniversary of the birth of our great nation and the signing of the Declaration of Independence that this day represents.
This measure would recognize August 15, 2018, as India's Independence Day, and urge all Californians to join in celebrating India's independence.
This measure would proclaim the month of July 2018 as Uterine Fibroids Awareness Month in California and would recognize the need for greater research, treatment, and care options regarding uterine fibroids.
This measure would proclaim October 9th as Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) Awareness Day in California, and would encourage the citizens of California, on that day, to become informed and aware of PANS.
This measure would recognize the legacy of California's pioneer Chinese Americans and honor their contributions and the important role they played in the history of Yosemite National Park and the Sierra Nevada.
This measure would designate August 16, 2018, as Pre-Exposure Prophylaxis and Post-Exposure Prophylaxis Awareness Day in California to enhance public awareness of comprehensive human immunodeficiency virus prevention strategies.
This measure would urge the Congress of the United States to acknowledge the problem of a labor shortage in the agricultural industry in California and to work together with California to solve the issue.
(1) The Control, Regulate and Tax Adult Use of Marijuana Act of 2016 (AUMA) , an initiative measure approved as Proposition 64 at the November 8, 2016, statewide general election, authorizes a person who obtains a state license under AUMA to engage in commercial adult-use cannabis activity pursuant to that license and applicable local ordinances. The Medicinal and Adult-Use Cannabis Regulation and Safety Act (MAUCRSA) , among other things, consolidates the licensure and regulation of commercial medicinal and adult-use cannabis activities. MAUCRSA generally divides responsibility for the state licensure and regulation of commercial cannabis activity among the Department of Consumer Affairs, the Department of Food and Agriculture, and the State Department of Public Health and requires those state licensing authorities to begin issuing licenses by January 1, 2018. Under existing law, the Department of Food and Agriculture may issue cannabis cultivation licenses to commercial cannabis businesses that differ depending on the size of the cultivation site and whether the site is indoor, outdoor, or mixed. AUMA also requires the Department of Food and Agriculture, in consultation with the Bureau of Cannabis Control, to implement a unique identification program for cannabis and requires a unique identifier to be issued for each cannabis plant at a cultivation site during the cultivation period, as specified. AUMA, as amended by MAUCRSA, defines a "unique identifier" as referencing a specific plant on a licensed premises, and any cannabis or cannabis products derived from that plant. AUMA, as amended by MAUCRSA, requires the department, in consultation with the bureau, to use these unique identifiers in a track and trace program that tracks the movement of cannabis and cannabis products throughout the distribution chain, from cultivation to sale, using a software tracking system. This bill would define "immature cannabis plant" for purposes of AUMA. The bill would provide for a unique identifier that references the lot of plants to which an immature plant belongs, instead of requiring a unique identifier for each immature plant, as specified. (2) AUMA authorizes the Legislature to amend AUMA to further the purposes and intent of AUMA with a 23 vote of the membership of both houses of the Legislature, except as provided. This bill would declare that its provisions further the purposes and intent of AUMA.
Existing law requires the State Department of Public Health to establish a list of reportable communicable and noncommunicable diseases and conditions and specify the timeliness requirements related to the reporting of each disease and condition. Existing law also supports research into the development of a vaccine to protect against coccidioidomycosis, also known as Valley Fever. This bill would require the department, when it receives a report of a case of coccidioidomycosis after the department's reporting deadline for a specified year, to include the case in its data collection for the next year and attribute it to the year of diagnosis in future data reporting. This bill would require the department to collect data on coccidioidomycosis cases by April 15 of each year, as specified. The bill would require the department, if it collects data on coccidioidomycosis cases and removes discrepant data from its internal dataset, to timely report sufficient information about its removal of the discrepant data to a local health officer and the local health officer may remove the discrepant data from the county's dataset. The bill would also require the department, if it publishes provisional data on coccidioidomycosis cases, to publish an explanation of data changes likely to occur and of discrepancies between data reported by a local health officer and data reported by the department. The bill would require the department to publish the date range of a dataset and the date on which the dataset was updated if the department publishes data on coccidioidomycosis cases.
Existing law requires the State Department of Public Health to establish a list of reportable diseases and conditions. Existing law requires, for each reportable disease and condition, the department to specify the timeliness requirements related to the reporting of each disease and condition, and the mechanisms required for, and the content to be included in, reports made. This bill would, until January 1, 2024, authorize the department, for the purpose of reports confirming a case of Valley Fever, to use laboratory criteria for diagnosis, with or without clinical criteria.
